ondansetron has been researched along with Female Genital Diseases in 6 studies
Ondansetron: A competitive serotonin type 3 receptor antagonist. It is effective in the treatment of nausea and vomiting caused by cytotoxic chemotherapy drugs, including cisplatin, and has reported anxiolytic and neuroleptic properties.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Postoperative nausea and vomiting (PONV) is still a common perioperative complication and ondansetron has proved to be an effective antiemetic substance in its prevention." | 10.18 | [Prevention of postoperative nausea and vomiting with single and repeat administration of ondansetron--review of the literature on different administration forms]. ( Buhre, W; Kazmaier, S; Mühr, C; Neumann, P; Saur, P, 1996) |
| "This randomized, double-blind, multicentre, parallel-group study compared the efficacy and safety of an intravenous dose of ondansetron 4 mg for the prevention of postoperative nausea and vomiting (PONV) with metoclopramide 10 mg and placebo in patients undergoing major gynaecological surgery." | 9.08 | [Intravenous administration of ondansetron vs. metoclopramide for the prophylaxis of postoperative nausea and vomiting]. ( Rust, M, 1995) |
| " Patients received one of four regimens for the prevention of postoperative nausea and vomiting (PONV): ondansetron 4 mg (n = 25), dexamethasone 8 mg (n = 25), ondansetron with dexamethasone (4 mg and 8 mg, respectively, n = 25) or placebo (saline, n = 25) There were no differences in background factors or factors related to operation and anaesthesia, morphine consumption, pain or side effects between groups." | 9.08 | Combination of ondansetron and dexamethasone in the prophylaxis of postoperative nausea and vomiting. ( Busto, N; Carrascosa, F; López-Olaondo, L; Monedero, P; Pueyo, FJ; Sáez, A, 1996) |
| "The efficacy and safety of ondansetron in preventing postoperative nausea and vomiting following major gynaecological surgery was evaluated in this multicentre, double-blind study." | 9.07 | The effect of oral ondansetron in the prevention of postoperative nausea and vomiting after major gynaecological surgery performed under general anaesthesia. ( Conseiller, C; Dupeyron, JP; Gribomont, B; Hemmingsen, C; Kaplan, LA; Levarlet, M; Pedersen, FM; Schoeffler, P, 1993) |
| "Postoperative nausea and vomiting (PONV) is still a common perioperative complication and ondansetron has proved to be an effective antiemetic substance in its prevention." | 6.18 | [Prevention of postoperative nausea and vomiting with single and repeat administration of ondansetron--review of the literature on different administration forms]. ( Buhre, W; Kazmaier, S; Mühr, C; Neumann, P; Saur, P, 1996) |
| "A total of 1442 patients who had major gynaecological surgery were recruited into three multicentre studies using a standard general anaesthetic technique in order to assess the efficacy of various doses of orally administered ondansetron in the prevention of postoperative nausea and vomiting." | 6.17 | Nausea and vomiting after gynaecological surgery: a meta-analysis of factors affecting their incidence. ( Dupeyron, JP; Durham, JM; Haigh, CG; Harmer, M; Kaplan, LA; Kenny, GN, 1993) |
| "To compare the efficacy of ondansetron-dexamethasone combination with ondansetron alone for prevention of postoperative nausea and vomiting (PONV)." | 5.09 | Comparison of ondansetron with ondansetron and dexamethasone in prevention of PONV in diagnostic laparoscopy. ( Batra, YK; Bhardwaj, N; Dhaliwal, LK; Rajeeva, V, 1999) |
| "This randomized, double-blind, multicentre, parallel-group study compared the efficacy and safety of an intravenous dose of ondansetron 4 mg for the prevention of postoperative nausea and vomiting (PONV) with metoclopramide 10 mg and placebo in patients undergoing major gynaecological surgery." | 5.08 | [Intravenous administration of ondansetron vs. metoclopramide for the prophylaxis of postoperative nausea and vomiting]. ( Rust, M, 1995) |
| " Patients received one of four regimens for the prevention of postoperative nausea and vomiting (PONV): ondansetron 4 mg (n = 25), dexamethasone 8 mg (n = 25), ondansetron with dexamethasone (4 mg and 8 mg, respectively, n = 25) or placebo (saline, n = 25) There were no differences in background factors or factors related to operation and anaesthesia, morphine consumption, pain or side effects between groups." | 5.08 | Combination of ondansetron and dexamethasone in the prophylaxis of postoperative nausea and vomiting. ( Busto, N; Carrascosa, F; López-Olaondo, L; Monedero, P; Pueyo, FJ; Sáez, A, 1996) |
| "The efficacy and safety of ondansetron in preventing postoperative nausea and vomiting following major gynaecological surgery was evaluated in this multicentre, double-blind study." | 5.07 | The effect of oral ondansetron in the prevention of postoperative nausea and vomiting after major gynaecological surgery performed under general anaesthesia. ( Conseiller, C; Dupeyron, JP; Gribomont, B; Hemmingsen, C; Kaplan, LA; Levarlet, M; Pedersen, FM; Schoeffler, P, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rust, M | 1 |
| Haigh, CG | 1 |
| Kaplan, LA | 2 |
| Durham, JM | 1 |
| Dupeyron, JP | 2 |
| Harmer, M | 1 |
| Kenny, GN | 1 |
| Conseiller, C | 1 |
| Levarlet, M | 1 |
| Hemmingsen, C | 1 |
| Schoeffler, P | 1 |
| Pedersen, FM | 1 |
| Gribomont, B | 1 |
| López-Olaondo, L | 1 |
| Carrascosa, F | 1 |
| Pueyo, FJ | 1 |
| Monedero, P | 1 |
| Busto, N | 1 |
| Sáez, A | 1 |
| Saur, P | 1 |
| Mühr, C | 1 |
| Kazmaier, S | 1 |
| Neumann, P | 1 |
| Buhre, W | 1 |
| Rajeeva, V | 1 |
| Bhardwaj, N | 1 |
| Batra, YK | 1 |
| Dhaliwal, LK | 1 |
2 reviews available for ondansetron and Female Genital Diseases
| Article | Year |
|---|---|
Nausea and vomiting after gynaecological surgery: a meta-analysis of factors affecting their incidence.
Topics: Adolescent; Adult; Age Factors; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; | 1993 |
[Prevention of postoperative nausea and vomiting with single and repeat administration of ondansetron--review of the literature on different administration forms].
Topics: Adult; Aged; Antiemetics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration | 1996 |
6 trials available for ondansetron and Female Genital Diseases
| Article | Year |
|---|---|
[Intravenous administration of ondansetron vs. metoclopramide for the prophylaxis of postoperative nausea and vomiting].
Topics: Adult; Double-Blind Method; Female; Genital Diseases, Female; Humans; Injections, Intravenous; Metoc | 1995 |
Nausea and vomiting after gynaecological surgery: a meta-analysis of factors affecting their incidence.
Topics: Adolescent; Adult; Age Factors; Aged; Dose-Response Relationship, Drug; Double-Blind Method; Female; | 1993 |
The effect of oral ondansetron in the prevention of postoperative nausea and vomiting after major gynaecological surgery performed under general anaesthesia.
Topics: Adolescent; Adult; Aged; Anesthesia, General; Belgium; Double-Blind Method; Drug Administration Sche | 1993 |
Combination of ondansetron and dexamethasone in the prophylaxis of postoperative nausea and vomiting.
Topics: Adolescent; Adult; Aged; Antiemetics; Dexamethasone; Double-Blind Method; Drug Therapy, Combination; | 1996 |
[Prevention of postoperative nausea and vomiting with single and repeat administration of ondansetron--review of the literature on different administration forms].
Topics: Adult; Aged; Antiemetics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration | 1996 |
Comparison of ondansetron with ondansetron and dexamethasone in prevention of PONV in diagnostic laparoscopy.
Topics: Adult; Ambulatory Care; Antiemetics; Dexamethasone; Double-Blind Method; Drug Combinations; Female; | 1999 |